盐酸帕罗西汀片对慢性心力衰竭伴抑郁障碍患者左心室功能及情绪障碍的影响

Effect of Paroxetine Hydrochloride Tablets on left ventricular function and emotional disorders in patients with chronic heart failure and depression

ES评分 0

DOI
刊名
Journal of International Psychiatry
年,卷(期) 2018, 45(4)
作者
作者单位

延安大学附属医院老年病科 ;
延安大学附属医院重症医学科 ;

摘要
摘要 探讨抗抑郁药盐酸帕罗西汀片对慢性心衰伴抑郁患者左心室功能及情绪障碍的影响。方法 以我院收治86例慢性心衰伴抑郁障碍患者为研究对象,根据住院单双号分为对照组与观察组,每组各43例,患者入院后均予以常规强心药、利尿剂及ACEI类等降低心脏负荷、增强心肌收缩力药物治疗,并采用常规心理护理,观察组在基础治疗上予以盐酸帕罗西汀片治疗,对照组予以安慰剂治疗,两组均用药3个月,疗程结束后复查左心室舒张末期内径(LVEDD)、左心室收缩末期内径(LVESD)、左心室射血分数(LVEF)、心输出量(CO),并评估其抑郁程度,检测干预前后两组生化指标ALT(丙氨酸氨基转移酶)、AST(谷草转氨酶)、尿素氮(BUN)、血肌酐(SCr),使用超声心电图检测干预前后心功能变化,并观察不良反应。结果 干预后,两组左心室功能指标LVEDD、LVESD、LVEF较治疗前明显升高,HAMD、HAMA评分明显下降,且干预后观察组LVESD(3.3±0.1)mm、LVEF(54.5±4.7)%,均明显高于对照组(3.2±0.1)mm、(42.6±4.3)%,观察组HAMD、HAMA评分依次是(15.2±4.6)分、(10.2±4.3)分,均明显低于对照组(18.4±4.2)分、(13.5±4.7)分,差异均具有统计学意义(P<0.05);干预后两组心功能指标SV、CO、E/A、CI较干预前显著升高,ALT明显下降,与治疗前比较,差异均具有统计学意义(P<0.05),干预后,观察组心功能指标均明显优于对照组,但试验室指标AST、BUN、SCr均无明显改善,组间比较,差异无统计学意义(P>0.05);对照组不良反应总发生率18.60%,观察组9.30%,差异无统计学意义(P>0.05)。结论 盐酸帕罗西汀片可有效改慢性心力衰竭伴抑郁障碍患者左心室功能,缓解抑郁、焦虑情绪,对肝肾功能无明显影响,且未增加明显不良反应,临床可予以考虑。
Abstract
Abstract: Objective To investigate the effect of antidepressant Paroxetine Hydrochloride Tablets on left ventricular function and emotional disorders in patients with chronic heart failure (CHF) and depression. Methods 86 cases of patients with CHD and depression in our hospital were selected and divided into the control group and the observation group, 43 cases in each group. All patients were treated with routine drugs. On the basis, the observation group were treated with Paroxetine Hydrochloride Tablets and the control group were treated with placebo. Both groups were treated for 3 months. After treatment, the left ventricular end diastolic diameter (LVEDD), left ventricular end systolic diameter (LVESD), left ventricular ejection fraction (LVEF) and cardiac output (CO) were determined, and the degree of depression was evaluated. The biochemical indexes such as alanine aminotransferase (ALT), aspertate aminotransferase (AST), blood urea nitrogen (BUN) and serum creatinine (SCr) in the two groups were detected. The changes of cardiac function before and after treatment were detected by ECG, and adverse reactions were observed. Results After the intervention, LVEDD, LVESD and LVEF were significantly increased while HAMD and HAMA scores were significantly decreased in the two groups, and the changes of above indexes were more obvious in the observation group than the control group (P<0.05). After intervention, SV, CO, E/A and CI were significantly increased while ALT was significantly decreased in the two groups (P<0.05). After intervention, the cardiac function indexes in the observation group were significantly better than those in the control group. There were no significant differences in AST, BUN and SCr between the two groups (P>0.05). The total incidence of adverse reactions in the control group was 18.60% while that in the observation group was 9.30% (P>0.05). Conclusion Paroxetine Hydrochloride Tablets can effectively improve the left ventricular function in patients with CHF and depression. It can relieve depression and anxiety, without affecting liver and kidney function and without increasing adverse reactions.
关键词
关键词:帕罗西汀;慢性心力衰竭;左心室功能;情绪障碍
KeyWord
Key words: Paroxetine; Chronic heart failure; Left ventricular function; Emotional disorders
基金项目
页码 722-725
  • 参考文献
  • 相关文献
  • 引用本文

任阳,姜文娟*,谢圆媛,林芳. 盐酸帕罗西汀片对慢性心力衰竭伴抑郁障碍患者左心室功能及情绪障碍的影响 [J]. 国际精神病学杂志. 2018; 45; (4). 722 - 725.

  • 文献评论

相关学者

相关机构